Delivery Order SPE2DB20D2104-SPE2DB25FMTLZ

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop 50 MCG Spray 16GM, a pharmaceutical product, with a ceiling value of $1,605.36. The contract is a firm fixed price delivery order with a performance period ending on June 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,643.19 and is for the delivery of Fluticasone Prop 50 MCG Spray, a respiratory medication. The contract has a completion date of February 9, 2023 and is a firm fixed-price arrangement. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,370.82, is for the delivery of Fluticasone Prop 50 MCG Spray 16GM, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) contract with a completion date of February 5, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP 50 MCG SPRAY 16GM. The contract has a firm fixed price of $7,226.78 and a completion date of May 22, 2025. The contract is not set aside and is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC serves as a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,336.27 firm fixed-price contract is for the supply of Fluticasone Prop 50 MCG Spray 15.8ML, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 4566054160 - Fluticasone Prop 50 MCG Spray 16GM, a pharmaceutical product. The contract has a ceiling value of $5,104.16 and an ultimate completion date of October 9, 2024. The contract is a firm-fixed-price type with no set-aside designation. AmerisourceBergen Drug Corp. is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a $1,424.69 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a specific pharmaceutical product, Fluticasone Prop 50 mcg Spray 16gm, with a completion date of June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop 50 MCG Spray 16GM. The contract has a ceiling value of $2,903.99 and a performance period ending on May 1, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,698.24 contract is for the delivery of FLUTICASONE PROP 50 MCG SPRAY 16GM, a pharmaceutical product, with a period of performance ending on June 11, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop 50 mcg Spray, a prescription medication, with a ceiling value of $1,070.14. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMTLZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.33, is for the delivery of Fluticasone Prop 50 MCG Spray 16GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract is not set-aside.

Generated 9/16/25, 10:00 AM